Convergent synthesis of a steroidal antiestrogen-mitomycin C hybrid using “click” chemistry
Name
Essigmann_Convergent synthesis.pdf
Size
654.03 KB
Format
Adobe PDF
Checksum (MD5)
8696b8a933a836a8401b2c9ef072cab9
Author(s)
Hanson, Robert N.
Hua, Edward
Labaree, David
Hochberg, Richard B.
Proffitt, Kyle
Essigmann, John M.
Croy, Robert G.
Date Issued
September 2012
Journal
Organic & Biomolecular Chemistry
Publisher
Royal Society of Chemistry
Citation
Hanson, Robert N., Edward Hua, David Labaree, Richard B. Hochberg, Kyle Proffitt, John M. Essigmann, and Robert G. Croy. “Convergent Synthesis of a Steroidal Antiestrogen-Mitomycin C Hybrid Using ‘click’ Chemistry.” Organic & Biomolecular Chemistry 10, no. 42 (2012): 8501.
Version
Author's final manuscript
Abstract
A convergent synthesis of a novel estrogen receptor-targeted drug hybrid was developed based on structures of the potent anti-proliferative mitomycin C and the steroidal anti-estrogen RU 39411. The steroidal antiestrogen was prepared with an azido-triethylene glycoloxy linker while the mitomycin C derivative (porfirimycin) incorporated a complementary 7-N-terminal alkyne. The two components were ligated using the Huisgen [3 + 2] cycloaddition (“click”) reaction. Preliminary biological assays demonstrated that the final hybrid compound retained both potent anti-estrogenic and anti-proliferative activities.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1039/c2ob25902h
